Non-ST-elevation myocardial infarction in the Netherlands: room for improvement!

[1]  P. Damman,et al.  Treatment patterns of non-ST-elevation acute coronary syndrome patients presenting at non-PCI centres in the Netherlands and possible logistical consequences of adopting same-day transfer to PCI centres: a registry-based evaluation , 2019, Netherlands Heart Journal.

[2]  M. Schalij,et al.  Mortality differences in acute myocardial infarction patients in the Netherlands: The weekend‐effect , 2018, American heart journal.

[3]  J. Afilalo,et al.  Impact of an invasive strategy in the elderly hospitalized with acute coronary syndrome with emphasis on the nonagenarians , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  M. Farkouh,et al.  Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction , 2018, European heart journal.

[5]  E. Keeley,et al.  Medication Administration Delays in Non–ST Elevation Myocardial Infarction: Analysis of 1002 Patients Admitted to an Academic Medical Center , 2018, Critical pathways in cardiology.

[6]  J. Ottervanger,et al.  Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting , 2018, European heart journal. Cardiovascular pharmacotherapy.

[7]  M. Schalij,et al.  Nationwide claims data validated for quality assessments in acute myocardial infarction in the Netherlands , 2017, Netherlands Heart Journal.

[8]  H. Carvalho.  Management of non-ST-elevation myocardial infarction: A constant challenge , 2016 .

[9]  S. Raposeiras-Roubín,et al.  Mortality benefit of long-term angiotensin-converting enzyme inhibitors or angiotensin receptor blockers after successful percutaneous coronary intervention in non-ST elevation acute myocardial infarction. , 2016, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[10]  H. Carvalho,et al.  Management of non-ST-elevation myocardial infarction: A constant challenge. , 2016, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[11]  H. Bueno,et al.  Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013. , 2016, JAMA.

[12]  ngel,et al.  Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes: A Systematic Literature Review , 2016, Current cardiology reviews.

[13]  A. Jaffe,et al.  A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2015 .

[14]  A. Jaffe,et al.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[15]  Robyn Tamblyn,et al.  The Incidence and Determinants of Primary Nonadherence With Prescribed Medication in Primary Care , 2014, Annals of Internal Medicine.

[16]  G. Stone,et al.  Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes , 2013, Annals of Internal Medicine.

[17]  E. Braunwald,et al.  A tale of coronary artery disease and myocardial infarction. , 2012, The New England journal of medicine.

[18]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[19]  Alan S. Go,et al.  Population trends in the incidence and outcomes of acute myocardial infarction. , 2010, The New England journal of medicine.

[20]  E. Hannan.  Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. , 2008, JACC. Cardiovascular interventions.

[21]  Deepak L. Bhatt,et al.  Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. , 2006, Journal of the American College of Cardiology.

[22]  M. Schalij,et al.  Age and gender differences in medical adherence after myocardial infarction: Women do not receive optimal treatment – The Netherlands claims database , 2018, European journal of preventive cardiology.

[23]  A. Abizaid,et al.  "Let's not hurry, but let's not waste time": The importance of appropriate management of non-ST-elevation myocardial infarction. , 2018, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[24]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.